MORRISVILLE, N.C.–(BUSINESS WIRE)– Clinipace Worldwide, een wereldwijde full-service organisatie die klinisch onderzoek doet (CRO), heeft de benoeming van Charlene Dark als Vice President van global clinical analytics. In deze rol zal Dark verantwoordleijk zijn voor de operationele en commerciële levering van Clinipace’s data management, biostatistiek en statistische programmeringsfuncties.

Dark is een ervaren deskundige en innovator in datagestuurd operations management. Ze brengt 25 jaar aan ervaring met zich mee in het opbouwen van succesvolle analytische operaties. Onlangs werkte Dark nog aan het Infosario-platform van IQVIA. Eerder leidde ze verschillende datamanagementgroepen in haar rollen bij Omnicare Clinical Research, i3 en PPD.

“Ik heb voor Clinipace gekozen omdat het managementteam zich inzet om het bedrijf voorop te plaatsen op het gebied van innovatieve, klantgerichte levering. Het bedrijf doet de juiste investeringen op de juiste plaatsen”, aldus Dark. “We zijn goed uitgerust om geavanceerde oplossingen voor klinische analyse te ontwikkelen en uitmuntendheid te leveren aan onze klanten.”

Clinipace Worldwide Names Charlene Dark Vice President, Global Clinical Analytics

MORRISVILLE, N.C.–(BUSINESS WIRE)– Clinipace Worldwide, a global full-service clinical research organization (CRO), has announced the appointment of Charlene Dark as vice president, global clinical analytics. In her role, Dark will be responsible for operational and commercial delivery of Clinipace’s data management, biostatistics and statistical programming functions.

Dark is a well-known subject matter expert and innovator in data-driven operations management. She brings nearly 25 years of experience building successful analytics operations to Clinipace. Most recently, Dark worked on IQVIA’s Infosario platform. Previously, she led various data management groups in her roles at Omnicare Clinical Research, i3 and PPD.

“I chose to join Clinipace because the leadership team is committed to putting the company at the forefront of innovative, client centric delivery. The company is making the right investments in the right places,” said Dark. “We are well-equipped to develop cutting-edge, global, integrated clinical analytics solutions and deliver excellence to our clients.”

“The industry is moving to an evidence-based, data-driven way of working,” said Jason Monteleone, Clinipace CEO. “Charlene’s commitment to maximizing our technology investments and our agile, risk-based approach to building data management teams will help our clients access opportunities and innovations they cannot with other clinical research organizations. With her expertise, we will continue to reveal our capabilities as a leading midsized CRO.”

About Clinipace Worldwide

Clinipace Worldwide, a global full-service clinical research organization (CRO), helps to advance trials and deliver successful stakeholder and patient outcomes. The company leverages extensive therapeutic knowledge and clinical trial expertise to support life science firms in achieving their most important goals. Clinipace has completed more than 1,500 clinical trials and 1,500 regulatory and statistical consulting projects and operates in North America, South America, Europe and Asia-Pacific. To learn more, visit www.clinipace.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180510005273/en/

Contacts

SCORR Marketing
Lea Studer, +1 402-366-1752
lea@scorrmarketing.com